Other articles of interest

Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure

Philippe Garot, Pedro Cepas-Guillén, Eduardo Flores-Umanzor, Nina Leduc, Vilhemas Bajoras, Nils Perrin, Angela McInerney, Ana Lafond, Julio Farjat-Pasos, Xavi Millán, Sandra Zendjebil, Reda Ibrahim, Pablo Salinas, Ole de Backer, Ignacio Cruz-González, Dabit Arzamendi, Laura Sanchis, Luis Nombela-Franco, Gilles O¿Hara, Adel Aminian, Jens Erik Nielsen-Kudsk, Josep Rodés-Cabau, Xavier Freixa,
Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018

Jaime Díaz-Guzmán, Román Freixa-Pamias, Javier García-Alegría, Alejandro-Isidoro Pérez Cabeza, Inmaculada Roldán-Rabadán, Beatriz Antolin-Fontes, Pablo Rebollo, Aleix Llorac, Mar Genís-Gironés, Carlos Escobar-Cervantes,

Rev Esp Cardiol. 2022;75:496-505
Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

María Anguita-Gámez, David Vivas, Raquel Ferrandis, María Asunción Esteve-Pastor, Rafael González-Manzanares, Marysol Echeverri, Jesús Igualada, Isabel Egocheaga, Beatriz Nozal-Mateo, Ane Abad-Motos, Elena Figuero, Nuria Bouzó-Molina, Teresa Lozano, Carlos Álvarez-Ortega, Javier Torres, María José Descalzo, Juan Carlos Catalá, Enrique Martín-Rioboo, Alejandra Moliner, Rocío Rodríguez-Contreras, Manuel Carnero-Alcázar, Francisco Marín, Manuel Anguita,

Rev Esp Cardiol. 2025;78:416-24